Page 978 - Cardiac Nursing

LWBK340-ind_p941-958.qxd 7/1/09 10:37 AM Page 954 Aptara
LWB K34 0-i nd_ p94 1-9 58. qxd 7 / 1 / 09 10 :37 AM P a g e 95 4 A pta ra

954 Index

3LEEP CONTINUED 3TERNAL PRECAUTIONS D 4HROMBOEMBOLISM
RESTRICTION THERAPY 3TEWART APPROACH DEFINED
AND SLEEPINESS 3TIMULATION THRESHOLD LEVELS OF RISK WITHOUT PROPHALAXIS T

STAGES OF n F 3TIMULUS CONTROL 4HROMBOPHLEBITIS

AND STROKE 3TRESS ECHO n F 4HROMBOSIS n
SUBJECTIVE MEASUREMENT OF SLEEP 3TRETCHING CARDIAC FIBERS 4IGHT JUNCTION ENDOTHELIUM
THERMOREGULATION IN 3TROKE VOLUME VARIATION 366 4ILTING DISK VALVE
TWO PROCESS MODEL FOR REGULATION OF F 3TRONG ION GAP 3)' 4IMI FL W GRADE D

3LEEP DEPRIVATION 34 SEGMENT 4ISSUE PERFUSION MONITORING

3LEEP DISRUPTION F 3UBLINGUAL CAPNOGRAPHY F .)23

3LEEP DISTURBANCES MANAGEMENT 3UBSTRATE MAPPING IN 64 0 TC / n
COGNITIVE BEHAVIORAL THERAPY FOR 3UDDEN CARDIAC ARREST 3#! 3EE ALSO 3UDDEN 4ISSUE 0LASMINOGEN !CTIVATOR T 0!
COMPLEMENTARY AND ALTERNATIVE THERAPIES CARDIAC DEATH 3#$ 4OMOGRAPHIC IMAGING MODALITIES T
EDUCATION AND HYGIENE MANAGEMENT OF 4ONIC 2%- SLEEP
F

F
LIGHT THERAPY n !#,3 n 4ORSADES DE 0OINTES 4D0 n F
RELAXATION THERAPY AND IMAGERY !#,3 ALGORITHM n 4RADITIONAL #HINESE MEDICINE 4#-
SLEEP RESTRICTION THERAPY STRUCTURAL ABNORMALITY n 4RADITIONAL MEDICINE
STIMULUS CONTROL 3UDDEN CARDIAC DEATH 3#$ 3EE ALSO 3UDDEN 4RADITIONAL .ATIVE !MERICAN (EALING
3LEEP EFFICIENC CARDIAC ARREST 3#! 4RANSCELLULAR FLUID
3LEEPINESS CAUSE OF D 4RANSCENDENTAL MEDITATION D

DEFINITION OF DEFINITION OF 4RANSCUTANEOUS PACING n F
3LEEP PROPENSITY DAYTIME 3EE $AYTIME SLEEPINESS DUE TO #!$ F 4RANSCUTANEOUS TISSUE / 0 TC / n

3LEEP RELATED DISORDERED BREATHING DISORDERS NURSING MANAGEMENT OF 4RANSESOPHAGEAL ECHO 4%% n F F F
D

D
32"$ D n PRIMARY PREVENTION OF D F
3LEEP RELATED HYPOVENTILATION D SECONDARY PREVENTION OF D 4RANSFER ANXIETY
3LEEP RESTRICTION THERAPY STRUCTURAL ABNORMALITY n 4RANSIENT ISCHEMIC ATTACK 4)!
D
D
D
3LEEP WAKE SCHEDULE 373 WITHOUT STRUCTURAL HEART DISEASE n D D
D
3MOKING CESSATION 3UPERFICIAL TH OMBOPHLEBITIS 4RANSPULMONARY INDICATOR DILUTION 40)$

ALCOHOL USE 3UPERIOR 6ENA #AVA 36# F
AMONG WOMEN IN 5 3 3UPPLY ISCHEMIA 4RANSSEPTAL CATHETERIZATION n

BENEFITS O 3UPRAVENTRICULAR ARRHYTHMIAS T F

CLINICAL PRACTICE GUIDELINES n 3UPRAVENTRICULAR 4ACHYCARDIA 364 n 4RANSSEPTAL PUNCTURE OF FOSSA F
ASSISTANCE FOR n D 4RANSTHORACIC IMPEDANCE n F

FOLLOW UP GUIDELINES 3USTAINED MONOMORPHIC 64 T 4RANSVENOUS PACING F F

F
IDENTIFICATION OF USERS n D 3WAN 'ANZ CATHETER 4RANSVENOUS PACING LEAD F n
F
IDENTIFICATION OF USERS WILLING TO ATTEMPT 3YMPTOMATIC BRADYCARDIA n 4REPPE F

n 3YNCHRONIZED BRAIN WAVE 4RICUSPID ATRESIA n
STRONG URGE FOR 3YNCOPE n 4RICUSPID VALVE DISEASE n
CLINICAL USE OF PHARMACOTHERAPY T CLASSIFICATION OF D 4RIGLYCERIDE T
CONSIDERATIONS INTERNATIONAL DEFINED 4ROPIN n D
IN CORONARY HEART DISEASE n ELECTROCARDIOGRAPHY TESTING D 4RUNCUS ARTERIOSUS n
DEPRESSION AND 3YNTENY D 4 TUBULE SYSTEM
D
D
GENERAL TRENDS 3YSTEM RELATED PROCESS ORIENTED FACTORS OF 4UMOR NECROSIS FACTOR 4.&
HARMFUL EFFECTS OF n ADHERENCE T 4 7AVE D
LOSS IN 3YSTOLIC PRESSURE VARIATION 306 4WIDDLER SYNDROME
NURSES 3YSTOLIC RESERVE 4YPE DIABETES
SOCIAL SUPPORT FOR BETA CELL DEFECTS ASSOCIATED
STRESS AND T INSULIN RESISTANCE OF n
THEORETICAL FRAMEWORK FOR MEDICATION FOR
VULNERABLE POPULATIONS INCLUDE 4ACHYCARDIA PREVENTION OF n

WEIGHT GAIN AND n ALGORITHM FOR F 4YPE $IABETES -ELLITUS
WOMEN FASCICULAR 4YPE $-
3MOKING STATUS D JUNCTIONAL n 4YPE )) SECOND DEGREE !6 BLOCK n

3MOOTH MUSCLE CELLS SINUS F 4YPE ) SECOND DEGREE !6 BLOCK
3NORING VENTRICULAR
3ODIUM #ALCIUM EXCHANGE MONOMORPHIC TYPE n U

3ODIUM 0OTASSIUM !DENOSINE 4RIPHOSPHATASE POLYMORPHIC TYPE F
0UMP 4AI #HI 5PPER !IRWAY 2ESISTANCE 5!23
3ODIUM 0OTASSIUM PUMP 4AMAS 5REA NITROGEN
3OUND WAVES 3EE ALSO $OPPLER ECHO 4EMPORARY PACING INITIATION OF n 5RIC ACID
T
T
3PECIFICIT OF LABORATORY TEST T D 4ENECTEPLASE 4.+ T 0! 5 7AVE
3TAIRCASE PHENOMENON 4ERMINAL ARTERIOLES

3TAPHYLOCOCCUS AUREUS 4ETRALOGY OF &ALLOT F V
3TAPHYLOCOCCUS EPIDERMIDIS CLINICAL MANIFESTATION 6AGAL MANEUVERS
3TARLING S LAW DESCRIPTION 6ALSALVA MANEUVER n F
F
F

34 %LEVATION -) 34%-) MANAGEMENT 6ALVE DEGENERATION
ELECTROCARDIOGRAPHIC CHANGES T PATHOPHYSIOLOGY 6ARENICLINE T
T
T
CONTRAINDICATIONS OF T 4HEBESIAN VEINS 6ARIANT 0RINZMETAL ANGINA
3TENOSIS SEVERITY OF 4HERAPEUTIC ,IFESTYLE #HANGE 4,# 6ARICOSE VEINS
3TENTS CORONARY GUIDELINES FOR T 6ASCULAR ADHESION MOLECULE ) 6#!- )

"ARE -ETAL 3TENT "-3 4HERAPEUTIC TOUCH F 6ASCULAR CLOSURE DEVICES 6#$S
DEPLOYMENT OF 4HERMODILUTION 6ASCULAR ENDOTHELIUM RELATED TO VASOMOTOR
$RUG %LUTING 3TENT $%3 n 4HIAZOLIDINEDIONES 4:$ FUNCTION T
3TERNAL RISE 4HICK FILAMENTS 6ASCULAR SHEATH REMOVAL
4HIRD DEGREE !6 BLOCK n